BitGo, the leading institutional custody and digital asset finance provider, has officially integrated Injective.
In this groundbreaking collaboration, BitGo will seamlessly integrate INJ into its platform, enabling some of the most influential institutional players to securely deploy and safeguard their INJ holdings while delving deeper into the world of Injective. This in turn also allows both BitGo and Injective to make significant strides in advancing institutional DeFi adoption.
What Is BitGo?
BitGo stands at the forefront of digital asset security, custody, and liquidity services, providing the operational backbone for over 1,500 institutional clients spanning across more than 50 countries. This prestigious list includes regulated entities and the world's preeminent cryptocurrency exchanges and platforms.
Originally conceived as an air-gapped solution for Bitcoin storage, BitGo pioneered multi-signature wallets and now processes a staggering 20% of all global Bitcoin transactions by value. As one of the leading custodial solutions for finance institutions, BitGo recently announced its $100 million Series C funding round, valuing the company at $1.75 billion.
BitGo's Native INJ Integration
The core component of the integration is BitGo’s native support for INJ, the utility token used to power, secure and govern Injective.
With this collaboration, BitGo will natively support INJ, granting institutional players easy access to this essential asset through the trusted BitGo platform. One of Injective’s primary goals to create a seamless and secure DeFi environment for institutional players takes a significant step forward, bridging the divide between traditional and digital finance realms.
What Value Does BitGo Bring to Injective?
The collaboration between BitGo and Injective represents a monumental leap forward for the DeFi industry. It signifies a substantial focus towards mainstream adoption of decentralized finance by institutional giants. The synergy between BitGo and Injective underscores the vital role of bridging the gap between traditional finance and the burgeoning DeFi sector. This integration also is poised to serve a pivotal role in further solidifying Injective’s position at the forefront of institutional DeFi adoption.
As BitGo extends its support to INJ, the DeFi landscape becomes more inclusive and robust, benefiting both institutional players and the broader DeFi community. This collaboration serves as a beacon of hope for the future of decentralized finance, illuminating the path towards a more integrated and accessible financial ecosystem.
Injective is a lightning fast interoperable layer one blockchain optimized for building the premier Web3 finance applications. Injective provides developers with powerful plug-and-play modules for creating unmatched dApps. INJ is the native asset that powers Injective and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by prominent investors such as Jump Crypto, Pantera and Mark Cuban.
BitGo is a digital asset trust company offering a regulated custody, borrowing and lending platform. Founded in 2013 – the early days of crypto – BitGo pioneered the multi-signature wallet and later built TSS to improve upon other companies' MPC offerings. Today, BitGo is the leader in digital asset security, custody, and liquidity, providing the operational backbone for more than 1,500 institutional clients in over 50 countries – a list that includes many regulated entities and the world’s top cryptocurrency exchanges and platforms.